In the BioHarmony Drug Report Database
Nalbuphine
Nalbuphine, Nubain (nalbuphine) is a small molecule pharmaceutical. Nalbuphine was first approved as Nalbuphine on 1982-01-01. It is used to treat postoperative pain in the USA. The pharmaceutical is active against kappa-type opioid receptor, delta-type opioid receptor, and mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor.
Trade Name
|
Nalbuphine, Nubain |
|---|---|
Common Name
|
nalbuphine |
ChEMBL ID
|
CHEMBL895 |
Indication
|
postoperative pain |
Drug Class
|
Narcotic agonists/antagonists (normorphine type) |
Image (chem structure or protein)